U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07562178) titled 'Pemafibrate for Symptomatic ICAS RCT' on April 20.
Brief Summary: The goal of this clinical trial is to learn whether pemafibrate can help prevent worsening of intracranial arterial stenosis (ICAS) in patients who have symptomatic ICAS and high triglycerides (TG) levels after ischemic stroke or transient ischemic attack (TIA).
The main questions this study aims to answer are:
1. Does pemafibrate lower the chance that ICAS gets worse over 12 months?
2. Does pemafibrate improve TG levels and other vascular risk markers?
3. What are the effects of pemafibrate on vascular events, functional outcomes, and safety over 12 months?
Resear...